Taxotere and Embolic stroke - a phase IV clinical study of FDA data

Summary:

Embolic stroke is reported as a side effect among people who take Taxotere (docetaxel), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Compazine, and have Nausea.

The phase IV clinical study analyzes which people have Embolic stroke when taking Taxotere. It is created by eHealthMe based on reports of 62,318 people who have side effects when taking Taxotere from the FDA, and is updated regularly.

What is Taxotere?

Taxotere has active ingredients of docetaxel. It is often used in breast cancer. eHealthMe is studying from 62,513 Taxotere users. Check the latest studies of Taxotere.

What is Embolic stroke?

Embolic stroke (stroke due to obstruction due to an embolus) is found to be associated with 365 drugs and 542 conditions by eHealthMe. Check the latest studies of Embolic stroke.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

62,318 people reported to have side effects when taking Taxotere.
Among them, 12 people (0.02%) have Embolic stroke.

Among these 12 people:

How long have people been on Taxotere when they have Embolic stroke? *

What is the gender of people who have Embolic stroke when taking Taxotere? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Embolic stroke when taking Taxotere? *

What are other drugs people take besides Taxotere? *

What are other side effects people have besides Embolic stroke? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 33.33%
Arrhythmias (irregular heartbeat): 4 people, 33.33%
Constipation: 4 people, 33.33%
Metastatic Neoplasm (spreadable cancer tumour): 3 people, 25.00%
Fatigue (feeling of tiredness): 3 people, 25.00%
Unresponsive To Stimuli: 3 people, 25.00%
Anaemia (lack of blood): 3 people, 25.00%
Dizziness Postural: 3 people, 25.00%
Hydrocephalus (water on the brain): 3 people, 25.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 25.00%

What are the existing conditions these people have? *

Pain: 4 people, 33.33%
Nausea (feeling of having an urge to vomit): 4 people, 33.33%
Lung Carcinoma Cell Type Unspecified Stage Iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver): 3 people, 25.00%
Diarrhea: 3 people, 25.00%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 8.33%
Prostate Cancer Metastatic: 1 person, 8.33%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Nausea And Vomiting: 1 person, 8.33%
Muscle Spasms (muscle contraction): 1 person, 8.33%
Hot Flush (sudden feelings of heat): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Taxotere and have Embolic stroke?

- Check whether Embolic stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Taxotere:

Taxotere (62,513 reports)

Embolic stroke treatments and more:

Embolic stroke (4,762 reports)

Browse all side effects of Taxotere:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Embolic stroke:

Embolic stroke (365 drugs)

Browse all the conditions that are associated with Embolic stroke:

Embolic stroke (542 conditions)

Related publications that referenced our studies

Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on docetaxel (the active ingredients of Taxotere) and Taxotere (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.